Type 2 diabetes mellitus (T2DM) patients are often accompanied by hypertension and various acute or chronic complications that may activate or inhibit the renin-angiotensin-aldosterone system (RAAS), leading to increased rates of hospitalization and mortality [12–15]. This evidence concerns the gene REN and type 2 diabetes mellitus.